In the United States there are approximately 36,000 new cases of kidney cancer each year, and 12,000 individuals die from the disease. Kidney cancer is an international disease. New syndromes are being recognized and characterization of the associated symptoms as well as identification of the genes involved in the disease are important to develop appropriate therapies. Continuation of this project is of great importance because, at the moment, there are families with kidney cancer that do not have any of their genetic changes known. Therefore we need to study these families morphologically and genetically, as well as try to identify new proteins useful as tumor markers.
The specific aims of this study are to: 1) Define the types and morphological characteristics of new renal syndromes;2) Identify the genes and molecular changes responsible for these new syndromes;3) Identify genotype/ phenotype correlation;and 4) Study the associated lesions such as uterine and other smooth muscle tumors, skin, lung and ovarian tumors, and investigate if they share similar genetic changes. Continuation of this research is essential;first, because these tumors can only be recognized by their morphology and secondly, because we lack both markers for early detection and good forms of therapy.
|Vocke, Cathy D; Ricketts, Christopher J; Merino, Maria J et al. (2017) Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer 56:484-492|
|Linehan, W Marston; Merino, Maria J; Ricketts, Christopher J (2016) Papillary Renal-Cell Carcinoma. N Engl J Med 374:1991|
|Bi, Mark; Zhao, Siming; Said, Jonathan W et al. (2016) Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A 113:2170-5|
|Fascelli, Michele; Rais-Bahrami, Soroush; Sankineni, Sandeep et al. (2016) Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population. Urology 88:125-34|
|Lang, Martin; Vocke, Cathy D; Merino, Maria J et al. (2015) Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors. Mod Pathol 28:1458-69|
|Karageorgiadis, Alexander S; Papadakis, Georgios Z; Biro, Juliana et al. (2015) Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab 100:141-8|
|Zilbermint, Mihail; Xekouki, Paraskevi; Faucz, Fabio R et al. (2015) Primary Aldosteronism and ARMC5 Variants. J Clin Endocrinol Metab 100:E900-9|
|Rioux-Leclercq, Nathalie; Ferran, Algaba; Mahul, Amin et al. (2014) [Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]. Ann Pathol 34:448-61|
|Alimchandani, Meghna; Lara, Karlena; Tsokos, Maria et al. (2014) Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma. Urol Case Rep 2:39-62|
|Kauffman, Eric C; Ricketts, Christopher J; Rais-Bahrami, Soroush et al. (2014) Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11:465-75|
Showing the most recent 10 out of 47 publications